All In Biotech

Drug Trial Radar · NCT01677338

Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects

A Multi-center, Open-label Comparison Study of a 13C-uracil Breath Test Versus 99mTechnetium Sulfur Colloid Gastric Emptying Scintigraphy to Evaluate Normal, and Delayed Gastric Emptying Time in Dyspeptic Subjects

Last checked: Nov 20, 2026Latest source record: Apr 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Jul 2013

Primary completion

Jun 2014

Study completion Jul 2014

Sponsor

Sponsor type
Industry
Collaborators
Covance
First posted
Sep 3, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 21 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multi-center, open-label comparison study and aimed to evaluate the preliminary performance of this 13C-uracil GEBT to examine its abilities of identifying abnormal (delayed) gastric emptying rates in subjects.

Conditions

  • Dyspeptic Subjects

Interventions

  • 13C-uracilDrug

    PO, the Semi-solid Test Meal containing 100 mg of 13C-uracil . Perform the Breath Test.

  • 99mTc sulfur colloidDrug

    PO, the Solid Test Meal containing 500 uCi 99mTc sulfur colloid. Perform the Scintigraphy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Expired 13CO2 concentrationsTime frame: 6 hours

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Compass Research

    Orlando, Florida

  • Dartmouth-Hitchcock Medical Center, Gastroenterology and Hepatology

    Lebanon, New Hampshire

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.